Multiple primary cancers in families with Li-Fraumeni syndrome (Q44955059)

7 December 2017

title

Multiple primary cancers in families with Li-Fraumeni syndrome (English)

1 reference

7 December 2017

Hisada M

1 reference

7 December 2017

Garber JE

1 reference

7 December 2017

Fung CY

1 reference

7 December 2017

Fraumeni JF Jr

1 reference

7 December 2017

Li FP

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 April 1998

1 reference

Journal of the National Cancer Institute

7 December 2017

published in

1 reference

7 December 2017

1 reference

7 December 2017

1 reference

7 December 2017

page(s)

606-611

1 reference

Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

Genetic and pathologic findings in a kindred with hereditary sarcoma, breast cancer, brain tumors, leukemia, lung, laryngeal, and adrenal cortical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

Tumor-specific loss of 11p15.5 alleles in del11p13 Wilms tumor and in familial adrenocortical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

Familial aggregation of cancer from proband cases with childhood adrenal cortical carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

p53 and the Li-Fraumeni syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

The Li-Fraumeni syndrome: from clinical epidemiology to molecular genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

Analysis of relative survival and proportional mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

Acute leukemia complicating treatment of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

Mortality from second tumors among long-term survivors of retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

The molecular basis of Turcot's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

Mutations in the p53 gene occur in diverse human tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

The p53 tumour suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

A novel deletion within exon 6 of TP53 in a family with Li-Fraumeni-like syndrome, and LOH in a benign lesion from a mutation carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

Li-Fraumeni syndrome – a molecular and clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

Long-term risk of sarcoma following radiation treatment for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

Second cancer risk following Hodgkin's disease: a 20-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

Breast cancer after treatment of Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

Solid cancers after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

Identification and management of inherited cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

Controversies in breast cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

Breast cancer screening in premenopausal women: current recommendations and opportunities for research

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F90.8.606

21 January 2018

Identifiers

DOI

10.1093/JNCI/90.8.606

1 reference

7 December 2017

1 reference